Ambien and Omniscan drug interactions - a phase IV clinical study of FDA data
Drug interactions are reported among 148 people who take Ambien and Omniscan. Common interactions include pain in extremity among females, and nephrogenic systemic fibrosis among males.
The phase IV clinical study analyzes what interactions people who take Ambien and Omniscan have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
148 people who take Ambien and Omniscan together, and have interactions are studied.
What is Ambien?
Ambien has active ingredients of zolpidem tartrate. It is used in insomnia. Currently, eHealthMe is studying from 92,059 Ambien users.
What is Omniscan?
Omniscan has active ingredients of gadodiamide. Currently, eHealthMe is studying from 6,149 Omniscan users.
Number of Ambien and Omniscan reports submitted per year:
Ambien and Omniscan drug interactions by gender *:
Ambien and Omniscan drug interactions by age *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Ambien and Omniscan?Personalize this study to your gender and age
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Hsu FG, Sheu MJ, Lin CL, Hsieh YW, Lai SW, "Use of Zolpidem and Risk of Acute Pyelonephritis in Women: A Population‐Based Case‐Control Study in Taiwan", The Journal of Clinical Pharmacology, 2017 Mar .
- Lin SC, Su YC, Huang YS, Lee CC, "Zolpidem increased cancer risk in patients with sleep disorder: A 3-year follow-up study", Journal of Medical Sciences, 2016 Mar .
- Sun Y, Lin CC, Lu CJ, Hsu CY, Kao CH, "Association between zolpidem and suicide: a nationwide population-based case-control study", InMayo Clinic Proceedings, 2016 Mar .
- Liao KF, Lin CL, Lai SW, Chen WC, "Zolpidem use associated with increased risk of pyogenic liver abscess: a case-control study in Taiwan", Medicine, 2015 Jan .
Drug side effects by duration, gender and age:
Common Ambien drug interactions:
- Ambien and Aspirin: 10,346 reports
- Ambien and Xanax: 9,383 reports
- Ambien and Prednisone: 7,399 reports
- Ambien and Synthroid: 7,054 reports
- Ambien and Lisinopril: 6,980 reports
- Ambien and Nexium: 6,745 reports
- Ambien and Gabapentin: 6,443 reports
- Ambien and Cymbalta: 6,361 reports
- Ambien and Lipitor: 6,289 reports
- Ambien and Lasix: 6,254 reports
Browse interactions between Ambien and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Omniscan drug interactions:
- Omniscan and Magnevist: 3,075 reports
- Omniscan and Optimark: 2,409 reports
- Omniscan and Multihance: 2,137 reports
- Omniscan and Prohance: 1,899 reports
- Omniscan and Renagel: 724 reports
- Omniscan and Prednisone: 644 reports
- Omniscan and Coumadin: 583 reports
- Omniscan and Phoslo: 472 reports
- Omniscan and Aspirin: 408 reports
- Omniscan and Norvasc: 397 reports
Browse interactions between Omniscan and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
How the study uses the data?
The study uses data from the FDA. It is based on zolpidem tartrate and gadodiamide (the active ingredients of Ambien and Omniscan, respectively), and Ambien and Omniscan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Ambien and Omniscan.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Omeprazole and Low Turnover Osteopathy - 7 seconds ago
- Vitamin E and Kalbitor drug interaction - 10 seconds ago
- Piroxicam and Melphalan drug interaction - 10 seconds ago
- Mesalamine and Advair Diskus 100/50 drug interaction - 12 seconds ago
- Xalkori and Swelling Face - 14 seconds ago
- Zolpidem and Technescan drug interaction - 18 seconds ago
- Depo-Provera and Fibula Fracture - 19 seconds ago
- Mavik and Dehydration - 20 seconds ago
- Fluticasone Propionate and Crying - 20 seconds ago
- Catapres and Anaemia Of Chronic Disease - 21 seconds ago